¡¶Preventive Medicine Reports¡·£ºDifferences and similarities in breast and colorectal screening participation: a spatial and temporal analysis to reveal intervention areas, France
±à¼ÍƼö£º
¡¡¡¡Ä¿µÄ(Objective)£º¾¡¹ÜÈéÏÙ°©Óë½áÖ±³¦°©(colorectal cancer, CRC)¾ùÒÑÄÉÈëÓÐ×é֯ɸ²éÏîÄ¿(organized screening programs)£¬µ«²ÎÓëÂÊÈÔ²»ÀíÏëÇÒÓ°ÏìÒòËØÒÑ·¢Éú±ä»¯¡£±¾Ñо¿Ìá³öÒ»Öֿɸ´Ïֵķ½·¨£¬ÓÃÓÚ¿ÉÊÓ»¯ÉÏÊö
¡¡¡¡
Ä¿µÄ(Objective)£º¾¡¹ÜÈéÏÙ°©Óë½áÖ±³¦°©(colorectal cancer, CRC)¾ùÒÑÄÉÈëÓÐ×é֯ɸ²éÏîÄ¿(organized screening programs)£¬µ«²ÎÓëÂÊÈÔ²»ÀíÏëÇÒÓ°ÏìÒòËØÒÑ·¢Éú±ä»¯¡£±¾Ñо¿Ìá³öÒ»Öֿɸ´Ïֵķ½·¨£¬ÓÃÓÚ¿ÉÊÓ»¯ÉÏÊöÁ½ÖÖɸ²éÏîÄ¿²ÎÓëÂÊ(participation rate)µÄʱ¿Õģʽ(spatiotemporal patterns)¡£
·½·¨(Methods)£º±¾Ñо¿ÎªÉú̬ѧÑо¿(ecological study)£¬ÄÉÈë·¨¹úÂÞÄÉÊ¡(Rh?ne department)¼°Àï°º´ó¶¼»áÇø(Lyon metropolitan area)¹²751¸öÈË¿ÚÆÕ²éÇø¿é(census block, ·¨³ÆIRIS)ÖÐ50¨C74ËêÅ®ÐÔµÄÈéÏÙɸ²é( mammography screening for breast cancer)Óë½áÖ±³¦É¸²é(colorectal cancer screening, CRCS / faecal immunochemical test FIT)²ÎÓëÂÊ¡£°´Á½¸öʱÆÚ½øÐзÖÎö¡ª¡ªÐ¹ÚÒßÇéǰ(pre, 2015¨C2019)ÓëйÚÒßÇéºó(post, 2020¨C2022)¡£²ÉÓÿռäͳ¼Æ¾Ö²¿ÄªÀ¼Ö¸Êý(Local Moran's I)ʶ±ðÁ½Ê±ÆÚÄڸ߲ÎÓëÓëµÍ²ÎÓë¾Û¼¯Çø(clusters of high/low participation)£¬²¢½«Á½ÆÚ½á¹ûµþ¼Ó»æÖÆÊ±¼äÑݱäͼ£¬½«ÆÕ²éÇø¿é·ÖΪ³ÖÐø¸ß²ÎÓë(consecutively high)¡¢³ÖÐøµÍ²ÎÓë(consecutively low)¡¢²ÎÓë¸ÄÉÆ(improved)¡¢²ÎÓë¶ñ»¯(worsened)ËÄÀà¡£½áºÏÇé¾³ÒòËØ(contextual factors)¶ÔÉÏÊöÇ÷ÊÆ½øÐÐÃèÊö¡£
½á¹û(Results)£ºµØÍ¼ÏÔʾ³öÃ÷ÏԵĿռä²îÒì(spatial disparities)¡£½áÖ±³¦É¸²é²ÎÓëÂÊÓÉÔ¼33%ÉýÖÁÔ¼38%(+5¸ö°Ù·Öµã)£¬ÈéÏÙɸ²é²ÎÓëÂÊÔòÎȶ¨ÔÚÔ¼49%¡£ÔÚÀï°º´ó¶¼»áÇø£¬¼´±ãÒ½ÁÆ·þÎñ¿É¼°ÐÔ(healthcare access)½ÏºÃ£¬µÍÊÕÈëÆÕ²éÇø¿éÈÔ±íÏÖ³öÁ½ÖÖɸ²éµÄ³ÖÐøµÍ²ÎÓë¡£ÔÚÂÞÄÉʡũ´åµØÇø£¬²ÎÓëÂÊËæÊ±¼äÓÐËù¸ÄÉÆ£¬È«¿ÆÒ½Éú¿ÉÓÃÐÔ(availability of general practitioners, GPs)ËÆºõÊǹؼü¾ö¶¨ÒòËØ¡£
½áÂÛ(Conclusions)£º¸Ã·½·¨¿ÉÖ±¹Û³ÊÏÖɸ²é²ÎÓëÂÊËæ¿Õ¼äÓëʱ¼äµÄ±ä»¯£¬Îª¾ö²ßÕßʶ±ðÐè¸ÉÔ¤ÇøÓò¡¢Öƶ¨ÊÊÓ¦µ±µØ±³¾°µÄ·À°©²ßÂÔ(prevention strategies)Ìṩ¹¤¾ß¡£
±¾ÎĶԷ¢±íÓÚ¡¶Preventive Medicine Reports¡·µÄÂÛÎÄ"Differences and similarities in breast and colorectal screening participation: a spatial and temporal analysis to reveal intervention areas, France"£¨Padilla CM et al., UMR U1309/RSMS, EHESP French School of Public Health, Rennes, France£©½øÐнâ¶Á×ܽᡣ
¡¾Ñо¿±³¾°ÓëÁ¢ÌâÒÀ¾Ý¡¿
ÈéÏÙ°©Óë½áÖ±³¦°©ÊÇ·¨¹ú¼°È«Çò°©Ö¢·¢²¡ÓëËÀÍöµÄÖ÷ÒªÔÒò¡£·¨¹úÓÐ×éÖ¯ÈéÏÙ°©É¸²é£¨50¨C74ËêÅ®ÐÔÿÁ½ÄêÒ»´ÎÃâ·ÑÈéÏÙXÏßÉãÓ° mammography£©Óë½áÖ±³¦°©É¸²é£¨Í¬ÐÔ±ðÈËȺÿÁ½ÄêÒ»´Î·à±ãÃâÒß»¯Ñ§¼ì²â faecal immunochemical test, FIT£¬ÑôÐÔÕßÐн᳦¾µ colonoscopy£©ÏîÄ¿£¬µ«ÕûÌå²ÎÓëÂʾùδ´ïÀíÏëˮƽ¡ª¡ª½üÄêÈéÏÙ°©É¸²é²ÎÓëÂÊÔ¼44.8%¨C48.5%£¬½áÖ±³¦°©É¸²éÔ¼34.2%£¬ÇÒ¼ÈÍù·¨¹úÑо¿¶àµ¥¶À¹Ø×¢µ¥Ò»°©ÖÖɸ²é£¬½ÏÉÙͬʱ±È½ÏÈéÏÙÓë½áÖ±³¦É¸²é²ÎÓëµÄ¿Õ¼ä·Ö²¼¡¢Ê±¼äÑݱ估¹²Í¬±³¾°¾ö¶¨ÒòËØ¡£±ÈÀûʱÓëÈðÊ¿Ñо¿Ìáʾɸ²é²ÎÓë´æÔÚµØÇø²îÒì¼°ÏîÄ¿¼ä¹ØÁª£¬¶ø·¨¹ú´Ë·½ÃæÖ¤¾ÝÓÐÏÞ¡£Òò´ËÑо¿ÈËÔ±ÒÔ·¨¹ú°Â¸¥Äù-ÂÞÄÉ-°¢¶û±°Ë¹´óÇø(Auvergne-Rh?ne-Alpes, AURA)ÂÞÄÉÊ¡£¨º¬³ÇÊл¯Àï°º´ó¶¼»áÇø Lyon Metropolitan Area, Lyon MA ÓëÒÔÅ©´åΪÖ÷µÄÂÞÄÉÊ¡ÆäÓàµØÇø Rh?ne department/dpt£©ÎªÑо¿ÇøÓò£¬ÔÚÆÕ²éÇø¿é£¨IRIS£¬Ô¼2000ÈË×îСÐÐÕþͳ¼Æµ¥Ôª£©³ß¶ÈÉÏ·ÖÎö2015¨C2022ÄêÁ½°©É¸²é²ÎÓëÂʵĿռä¾ÛÀàÌØÕ÷¼°ÒßÇéǰºóʱ¼ä±ä»¯£¬ÒÔʶ±ðÐèÖØµã¸ÉÔ¤µØÇø²¢Ì½ÌÖÉç»á¾¼ÃµØÎ»ÓëÒ½ÁÆ·þÎñ¿É¼°ÐÔ¶ÔÆäÓ°ÏìÒìͬ¡£
¡¾Ö÷Òª¼¼Êõ·½·¨ÓëÊý¾ÝÀ´Ô´¡¿
Ñо¿ÈËÔ±¿ªÕ¹ÃèÊöÐÔÉú̬ѧÑо¿(ecological study)£¬ÒÔAURA´óÇø°©Ö¢É¸²éе÷ÖÐÐÄ(Regional Cancer Screening Coordination Centre, CRCDC AURA)ÌṩµÄ2015¨C2022ÄêÅ®ÐÔ£¨50¨C74Ë꣩ÈéÏÙXÏßÉãÓ°¼°FITɸ²é²ÎÓëÊý¾ÝΪ»ù´¡£¬°´IRIS£¨·¨¹ú¹ú¼Òͳ¼ÆÓë¾¼ÃÑо¿Ëù INSEE ¶¨ÒåµÄ×îСÈË¿ÚÆÕ²éÇø¿é£©¾ÛºÏ¼ÆËã¸÷Çø¿é²ÎÓëÂÊ£¬ÅųýÎÞ»ò²»×ã10Ãû·ûºÏÌõ¼þÅ®ÐÔµÄÇø¿éºó×îÖÕÄÉÈë730¸öIRIS£¨Àï°º´ó¶¼»áÇø492¸ö£¬ÂÞÄÉÊ¡238¸ö£©¡£½«2015¨C2019Ä껮ΪйÚÒßÇéǰ(pre-COVID-19)£¬2020¨C2022ÄêΪйÚÒßÇéºó(post-COVID-19)¡£²ÉÓÃÈ«¾Ö¼°¾Ö²¿¿Õ¼ä×ÔÏà¹Ø£¨Global & Local Moran's I£¬queenÁÚ½ÓÈ¨ÖØ£©Ê¶±ðÁ½Ê±ÆÚ¸ßµÍ²ÎÓëÂʾÛÀà( High-High / Low-Low clusters, LISA)£¬ÔÙµþºÏÁ½Ê±ÆÚLISA½á¹û»®·ÖËÄÀàʱ¿Õ²ÎÓëÇ÷ÊÆ£º³ÖÐø¸ß²ÎÓë(consecutively high)¡¢³ÖÐøµÍ²ÎÓë(consecutively low)¡¢²ÎÓë¸ÄÉÆ(improved trend)¡¢²ÎÓë¶ñ»¯(worsened trend)¡£±³¾°±äÁ¿°üÀ¨ÖÁ×î½üÈéÏÙÉãÓ°»ú¹¹ÐгÌʱ¼ä£¨µØÀí¿É¼°ÐÔ geographic accessibility£©¡¢ÊÐÕò¼¶È«¿ÆÒ½ÉúDZÔÚ¿É´ïÐÔ£¨¾Ö²¿Ç±Ôڿɼ°ÐÔÖ¸±ê£¬»ùÓڸĽøÁ½²½Òƶ¯ËÑѰ·¨ enhanced two-step floating catchment area method, E2SFCA£©¡¢2020ÄêÈ«¹úÈË¿ÚÆÕ²éIRIS¼¶¼ÒÍ¥ÊÕÈëÖÐλÊý(median income)×÷Éç»á¾¼ÃµØÎ»(socioeconomic status, SES)´úÀíÖ¸±ê¡£ËùÓзÖÎöÓÃRÈí¼þ v4.4.1Íê³É¡£
¡¾Ñо¿½á¹û¡¿
3.1 Geographic distribution and clusters of both screenings£¨Á½ÖÖɸ²éµÄµØÀí·Ö²¼Óë¾Û¼¯£©
È«¾ÖĪÀ¼Ö¸Êý(Global Moran's I)ÈéÏÙɸ²é0.41¨C0.55¡¢½áÖ±³¦É¸²é0.42¨C0.48£¬¾ùÕýÏòÏÔÖø(p<0.05)£¬Ö¤Êµ´æÔÚ¿Õ¼ä×ÔÏà¹ØÓë¾Û¼¯¡£LISAͼÏÔʾ£ºÀï°º´ó¶¼»áÇøÄÚÁ½°©É¸²éµÍ²ÎÓëLow-Low¾ÛÀàÖØºÏ·Ö²¼ÓÚ¶«²¿½¼Çø£¨ÈçVaulx-en-Velin¡¢V¨¦nissieux¡¢Villeurbanne£©£»ÂÞÄÉÊ¡Äϲ¿¼ûÁ½°©É¸²éHigh-High¾ÛÀà¡£ÒßÇéǰºó¸ñ¾Ö»ù±¾Î¬³Ö£¬µ«²¿·ÖÇøÓò²ÎÓëÂÊÉÏÉý³¬Ô½Å·Ö޲ο¼ãÐÖµ¡£
3.2 Mapping of the spatiotemporal screening participation patterns£¨É¸²é²ÎÓëʱ¿ÕÄ£Ê½ÖÆÍ¼£©
µþºÏǰºóÆÚLISA½á¹ûÖÆ×÷Õ½ÂÔʱ¿ÕµØÍ¼¡£Àï°º´ó¶¼»áÇøÖж«²¿½¼ÇøIRIS³Ê³ÖÐøµÍ²ÎÓ루ÈéÏÙɸ²é14.2%¡¢½áÖ±³¦É¸²é10.5%£©£¬Ëä¾¶à´Î¸ÉÔ¤ÈÔδ¸ÄÉÆ£»ÂÞÄÉÊ¡Äϲ¿£¨Saint-Symphorien-d'Ozon¡¢MornantÇø£©³Ê³ÖÐø¸ß²ÎÓë¡£Àï°º´ó¶¼»áÇø²¿·ÖIRIS£¨µÚ8Çø¡¢St Priest¡¢Rilleux-la-Pape£©ÈéÏÙɸ²é²ÎÓë¶ñ»¯(8.3% vs ½áÖ±³¦3.4%, p£½0.013)£»ÂÞÄÉÊ¡ÈéÏÙɸ²é³ÖÐø¸ß²ÎÓë±ÈÀý(35.7%)¸ßÓÚ½áÖ±³¦(17.6%, p£½0.004)£¬ÇÒÈéÏÙɸ²é¸ÄÉÆÄ£Ê½¸ü³£¼û(15.5% vs 4.2%, p£½0.027)¡£±³¾°ÒòËØ·ÖÎöʾ£ºÀï°º´ó¶¼»áÇø³ÖÐøµÍ²ÎÓëIRISÖÐλÊÕÈ뼫µÍ£¨ÈéÏÙ€17,078£»½áÖ±³¦€16,816£©£¬¾¡¹ÜGP¿É¼°ÐÔÓëÖÁÈéÏÙ»ú¹¹¾àÀëÉпɣ¬Ìáʾ³ÇÊл·¾³ÖÐSES½ÏµØÀí¿É¼°ÐÔÓ°Ïì¸ü´ó£»ÂÞÄÉÊ¡¸ß/¸ÄÉÆ²ÎÓëIRIS¶ÔÓ¦¸ü¸ßGPÃܶÈÓë¸ü¶ÌÖÁÈéÏÙ»ú¹¹ÐгÌʱ¼ä£¬Ìáʾũ´å/°ëÅ©´åÇøÒ½ÁÆ·þÎñ¹©¸øÎª¹Ø¼ü¡£
¡¾ÌÖÂÛÓë½áÂÛ·Òë¡¿
±¾Ñо¿±íÃ÷ÈéÏÙɸ²é×ÜÌå²ÎÓëÂʸßÓÚ½áÖ±³¦É¸²é£¬µ«¶þÕß¾ù´æÔÚÃ÷ÏÔµØÀí²îÒì¼°²»Í¬Ê±¼äÑݱä¹ì¼£¡£Àï°º´ó¶¼»áÇø½ü½¼ÈõÊÆÈºÌå¾Û¾ÓÇøÁ½°©É¸²é³ÖÐøµÍ²ÎÓ룬¼´±ãÒ½ÁÆ·þÎñÎïÀí¿É¼°Ò²²»¸Ä¹Û£¬ÕâÓëµÍÊÕÈë¡¢ÒÆÃñ±ÈÀý¸ß¡¢ÓïÑÔÎÄ»¯Õϰ¼°½¡¿µÓÅÏÈÐòµÍÓйء£Ïà·´ÂÞÄÉÊ¡µÃÒæÓڵط½¶à²¿ÃŶàÄ꽡¿µ´Ù½øÐж¯¼°½ÏºÃGP¸²¸Ç£¬Äϲ¿³Ê³ÖÐø¸ß²ÎÓë¡¢±±²¿ÈéÏÙɸ²é²ÎÓë¸ÄÉÆ£¬Ìáʾũ´åÇøÒ½ÁÆ·þÎñ¹©¸øÖÁ¹ØÖØÒª¡£ÒßÇéÖ²¿·ÖÇøÓò²ÎÓëÔÝʱϽµ»ò¸ÄÉÆ²»Ò»¡£´Ë·½·¨ÕûºÏʱ¿ÕÓë±³¾°ÌØÕ÷£¬¿É¸´ÖÆÍƹ㣬ÖúÎÀÉú¾ö²ßÕßÔÚ΢µØÓò³ß¶È¶¨Î»¸ÉÔ¤°Ðµã²¢ÒòµØÖÆÒËÉè¼ÆÉ¸²é´Ù½ø²ßÂÔ¡£
Conclusion£¨ÔÎĽáÂÛÒâÒ룩£º±¾Ñо¿Ìá³öµÄʱ¿Õ¿ÉÊÓ»¯·½·¨¿É³ÊÏÖÈéÏÙ°©Óë½áÖ±³¦°©ÓÐ×é֯ɸ²é²ÎÓëÂʵĿռäÓëʱ¼ä·Ö²¼Ä£Ê½£¬ÎªÕþ²ßÖÆ¶¨Õßʶ±ðÐèÓÅÏȸÉÔ¤ÇøÓò¡¢²¢½áºÏµ±µØÉç»áÈË¿ÚÓëÒ½ÁÆ·þÎñ±³¾°µ÷ÕûÔ¤·À²ßÂÔÌṩʵÓù¤¾ß¡£